RACHEL HUYNH: Open Payments
NPI 1598328163 · FORT SMITH, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,080 in 73 payments from 11 companies in 2025. Trend: 2023 $112 · 2024 $856 · 2025 $1,080
Food & beverage: $1,080
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $304 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $278 |
| Alkermes, Inc. | 5 | $111 |
| Lundbeck LLC | 5 | $107 |
| Otsuka America Pharmaceutical, Inc. | 4 | $80 |
| Teva Pharmaceuticals USA, Inc. | 3 | $71 |
| Neurocrine BioSciences, Inc. | 2 | $36 |
| Janssen Pharmaceuticals, Inc | 1 | $27 |
| JAZZ PHARMACEUTICALS INC. | 1 | $26 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
Products named: VRAYLAR, CAPLYTA, REXULTI, ARISTADA, AUSTEDO XR, INGREZZA, SPRAVATO, XYWAV.
Industry payments across AR — which companies pay providers there.
